FDA Recalls Cheeky Bonsai Menthol Pain Relief Patches for Manufacturing Deviations
Cheeky Bonsai Pain Relief Patches (Menthol 10%) are being recalled nationwide due to manufacturing facility compliance deviations. The voluntary recall affects 17,928 patches distributed across the US.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary precautionary recall due to manufacturing facility compliance deviations (cGMP violations). No illnesses, injuries, or hospitalizations are documented in the recall notice. The FDA Class II classification with no documented adverse events and voluntary firm-initiated status align with the rubric's characterization of voluntary precautionary recalls as typically Moderate severity.
Plain-English summary
Cheeky Bonsai Pain Relief Patches containing 10% menthol are subject to a nationwide recall. The product is packaged with 4 patches per box and carries UPC 8 60006 57564 9.
The recall was voluntarily initiated by the manufacturer, Unexo Life Sciences Private Limited, based in New Delhi, India. The reason for the recall is that the manufacturing facility did not comply with current Good Manufacturing Practice (cGMP) requirements established by the FDA.
Approximately 17,928 patches have been distributed nationwide in the United States under the Cheeky Bonsai brand. The FDA assigned this recall the designation D-0071-2025 and classified it as a Class II recall.
The recalled product
- Product
- CHEEKY BONSAI PAIN RELIEF PATCHES, Menthol 10%, 4 patches per box, Distributed by Cheeky Bonsai, San Francisco, CA UPC 8 60006 57564 9
- Manufacturer
- Unexo Life Sciences Private Limited
- Category
- Drug — Topical Pain Relief
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UPC 8 60006 57564 9
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27